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Hemophagocytic lymphohistiocytosis (HLH) is the result of excessive cytokine 
release, leading to over-response by immune cells, such as macrophages and T 
lymphocytes. Here, we report a lethal case of HLH with a complete clinical course. 
The patient was a 45-year-old man with fever and chills since two months ago plus 
splenomegaly, hepatomegaly, and pancytopenia. The Anti-HBc IgM was positive, 
but the HBS antigen, anti-HCV, and HBS antibody were negative. Assessment for 
cirrhosis was carried out by FibroScan, which showed F4 grade. The biopsy sampling 
was impossible due to the low platelet count. During admission, generalized bleeding 
was developed and led to alveolar hemorrhage, which subsequently resulted in the 
patient's death. Liver necropsy certified the diagnosis of hemophagocytic syndrome. 
Overall, according to the reported case in this paper, it should be remembered that 
secondary HLH is an inflammatory phenomenon due to different conditions, such as 
latent newly-developed infections. 
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Introduction 
Hemophagocytic lymphohistiocytosis (HLH) is the 
result of excessive cytokine release, leading to over-
response by immune cells, such as macrophages and T 
lymphocytes (1–3). Primary and secondary types are 
the HLH subtypes (4). Definite diagnosis is difficult 
due to various manifestations (5, 6). Severe hyper-
inflammation is developed by activated macrophages 
and T lymphocytes (6). Children are usually affected 
by primary HLH versus secondary HLH in adults (7). 
Due to life-threatening consequences, HLH should be 
diagnosed and treated promptly to attain the best 
prognosis, especially in secondary cases (8). The case 
fatality rate of HLH is approximately 10% and is 
usually due to generalized visceral bleeding (6). 
However, the mortality in some treatment-focused 
studies with a larger sample population ranged from 
20% to 88% (9). Here, we report a lethal case of HLH 
with a complete clinical course. 
 
Case Report 
The patient was a 45-year-old male subject with 
fever and chills since two months ago without any 
specific circadian patterns. At initial admission, the 
body temperature was 38°C by oral measurement, and 
there was splenomegaly in clinical examination, which 
was detected by ultrasound as huge splenomegaly 
(diameter 84*205) plus hepatomegaly (span 155 mm). 
Normal liver size is 10.5 cm in men and 7 cm in 
women, and the spleen's largest size is 12–14 cm. Both 
kidneys had increased echo pattern with 
corticomedullary contrast, suggesting acute tubular 
necrosis. There was free fluid accumulation in pelvic 
and perihepatic regions. Also, there was a right-sided 
pleural effusion with a thickness of 188 mm. 
The Cytomegalovirus (CMV), Epstein-Barr virus 
(EBV), and Tuberculosis were assessed and ruled out. 
Lumbar puncture was not possible due to the low 
platelet count. The initial body temperature was 38°C 
and was up to 39°C during admission. Due to the 
inappropriate condition of the patient, the transfer was 
impossible. However, a computed tomography (CT) 
scan of various parts, presented by the patient, was total 
without any evidence of malignancy. Bone marrow 
aspiration and biopsy were normal, and macrophage 
was not seen. There were pancytopenia, high serum 
creatinine, and blood urea nitrogen, high (over 2000 
mg/dl) lactate dehydrogenase (LDH), hyperuricemia, 
and abnormal liver enzyme, as well as bilirubin levels, 
in laboratory assessment.  
The leukocyte count was as low as 1500 per mm³ at 
admission, and after one week reached 6800 per mm³. 
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In protein electrophoresis, the albumin and alpha 1 
proteins had low levels, but alpha 2 and gamma 
proteins had high levels. C-reactive protein (CRP) was 
positive, with a numerical amount of 15 mg/L, and 
erythrocyte sedimentation rate (ESR) was high (41 
mm/hr). The urinalysis showed 3+ and 4+ protein and 
blood in urine samples besides leukocyturia and mild 
bacteriuria. Venous blood gas analysis showed low 
Partial Pressure of Carbone Dioxide (PCO2), Base 
excess (BE), and Bicarbonate (HCO3) plus a high 
Partial Pressure of Oxygen (PO2) level. The anti-
double stranded test (Anti-dsDNA), Liver kidney 
microsome antibodies (Anti-LKM), Anti-smooth 
muscle antibody test (ASMA), Antinuclear Antibodies 
(ANA), Antineutrophil cytoplasmic antibodies (P-
ANCA, and C-ANCA) were all negative. The 
infectious causes for pancytopenia and huge 
splenomegaly, such as endocarditis, brucellosis, HIV 
infection, and leishmaniasis, were ruled out. The Anti-
HBC IgM was positive, but the HBS antigen, anti-
HCV, and HBS antibody were negative. A high 
procalcitonin level (7.9 ng/ml) was also seen. 
Assessment for cirrhosis was done by Liver 
Elastrography (FibroScan), which showed F4 grade 
and indicated the need for a liver biopsy by IQR/Med 
ratio of 20%. However, the biopsy sampling was 
impossible due to the low platelet count (113000 and 
56000 per mm³ at admission and after one week, 
respectively) and postponed till the normalization of 
the platelet count.  The international normalized ratio 
(INR) was 1.2, and Partial Thromboplastin Time (PTT) 
was as long as 60 s. One of the proposed differential 
diagnoses was a hemophagocytic syndrome. 
Accordingly, the ferritin and triglyceride levels were 
assessed. Also, the bone marrow biopsy was carried out 
to assess the macrophage aggregation, but it was 
negative. Dexamethasone was prescribed for the 
patient because of the high suspicion of hemopha-
gocytic syndrome.  
During admission, generalized bleeding was 
developed and led to alveolar hemorrhage, which 
subsequently resulted in the patient's death. Liver 
necropsy showed that there were many macrophages, 
and the diagnosis was by standard clinical criteria by 
the American Pathology Association (Figure 1). 
Regarding high fever, splenomegaly, pancytopenia, 
high ferritin, and high number of macrophages in 
necropsy, the patient had five out of eight criteria, and 




Figure 1.  Histopathological results of liver necropsy; there are many macrophages in the tissue 
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Table 1. The classification of superficial palmar arches according to 
 Coleman and Anson (from references 9) 
Test Amount NL 
ANA 1/40 Up to 1/80 
ESR 41 <15 
CRP 15 <3 
Anti-DS DNA 2 <30 
ASMA - - 
P-ANCA 0.3 <5 
C-ANCA 1.2 <5 
Wright 1/20 >1/80 
BUN 75 7-20 
Cr 3.5 0.8-1.4 
Uric acid 6 3.4-7 
LDH 2400 140-280 
AST 250 10-40 
ALT 362 7-56 
ALP 368 20-140 
Bil T 4.6 0.2-1.2 
Bil D 2.8  
INR 1.2 < 1.1 
PTT 60 40-50 
Ferritin 680 12-300 
TG 183 <150 
Procalcitonin 7.9 0.1-0.44 
 
Discussion
HLH is a potentially life-threatening condition with 
triggering pre-inflammatory factors. The middle-aged 
male patient, reported in this paper, had a two-month 
history of fever and chills and nearly the ten-day course 
of final life process from the hospital admission to final 
death. Dhawale et al. (10) reported an 18-year-old 
Indian male patient presenting with a two-month 
history of fever, generalized weakness, and weight 
loss, as seen in our patient. The diagnosed condition 
was established by the HLH-2004 criteria in their 
study. In their report, the patient was survived after that 
the pleural fluid was assessed microbiologically, and 
the presence of mycobacterium tuberculosis was 
demonstrated and led to standard therapy.  
Our patient had a positive result for anti-HBc IgM, 
suggesting a possible etiological role for hepatitis B 
infection. However, the only used treatment was 
dexamethasone that showed no life-saving effect and 
possibly led to further provocation of disease. 
Regarding high suspicion, high dose dexamethasone 
with a dose of 40 mg/day was initiated. Because of no 
definite diagnosis and incomplete criteria, as well as no 
satisfaction among the patient's relatives, 
chemotherapy was not initiated. 
Diagnostic criteria for HLH should minimally 
include the presence of five out of the eight criteria, 
including fever, splenomegaly, cytopenia (anemia, 
thrombocytopenia, and neutropenia), hypertrigl-
yceridemia or hypofibrinogenemia, hemophagocytosis 
in body organs without malignancy, low activity in 
natural killer cells, increased ferritin, and high CD25 
(11–13). However, less than five criteria were found in 
our study that led to delayed diagnosis despite high 
suspicion. 
Thomas et al. (14) reported five HLH cases with the 
expiration of four patients. One of the patients was died 
due to generalized hemorrhage, such as our reported 
case. The background conditions in their patients were 
immunological, infectious, and malignancies, showing 
the importance of the completion of diagnostic 
approaches in our study to detect the definite primary 
etiology. However, the recognition of background 
etiology would result in a further chance of treatment 
and life-saving attempts.  
Furthermore, Ferreira et al. (15) reported seven cases 
of HLH that led to two fatal cases. Also, the primary 
infections were Epstein–Barr virus, cytomegalovirus, 
and leishmaniasis in three, one, and two cases, 
respectively, with one idiopathic case. Aleem et al. (16) 
reported a patient that found to have evidence of 
chronic hepatitis B infection according to the 
serological tests and liver biopsy.  
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However, the patient in our study had acute hepatitis 
B infection according to positive IgM levels of anti-
HBc antibody. Also, Halfon et al. (17) reported a case 
of HLH due to acute Cytomegalovirus and Hepatitis-B 
Virus sexual co-infection, but the reported case in our 
study had no clear route of acquisition of hepatitis B 
infection. In Iran, a study by Shamsian et al. (18) 
reported six cases of primary HLH and their outcome 
from a single tertiary-care center in Tehran. 
 
Conclusion 
Totally, according to the reported case in this paper, 
it is concluded that secondary HLH is an inflammatory 
phenomenon due to different conditions, such as latent 
newly-developed infections. The patients would have a 
better prognosis if diagnosed and treated promptly with 
the goal-oriented treatment of background disease. 
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